General Session

Advances in Precision Therapy in CLL: Integrating BTK and BCL-2 Inhibition Across the Treatment Continuum

45 min
Friday, October 16, 2026
8:50 AM - 9:35 AM
Supported by educational grants from AstraZeneca and BeOne.
  • Room
    • Broadway South
share
Back to top